ACB
Price
$4.84
Change
+$0.03 (+0.62%)
Updated
Jul 25 closing price
Capitalization
238.86M
10 days until earnings call
AKAN
Price
$1.27
Change
+$0.01 (+0.79%)
Updated
Jul 25 closing price
Capitalization
1.25M
Interact to see
Advertisement

ACB vs AKAN

Header iconACB vs AKAN Comparison
Open Charts ACB vs AKANBanner chart's image
Aurora Cannabis
Price$4.84
Change+$0.03 (+0.62%)
Volume$721.18K
Capitalization238.86M
Akanda
Price$1.27
Change+$0.01 (+0.79%)
Volume$19.33K
Capitalization1.25M
ACB vs AKAN Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. AKAN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and AKAN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ACB: $4.84 vs. AKAN: $1.27)
Brand notoriety: ACB: Notable vs. AKAN: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 58% vs. AKAN: 44%
Market capitalization -- ACB: $238.86M vs. AKAN: $1.25M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. AKAN’s [@Pharmaceuticals: Other] market capitalization is $1.25M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileAKAN’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • AKAN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACB and AKAN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 5 TA indicator(s) are bullish while AKAN’s TA Score has 4 bullish TA indicator(s).

  • ACB’s TA Score: 5 bullish, 5 bearish.
  • AKAN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACB is a better buy in the short-term than AKAN.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а +6.84% price change this week, while AKAN (@Pharmaceuticals: Other) price change was +4.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

ACB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than AKAN($1.25M). ACB YTD gains are higher at: 13.882 vs. AKAN (-20.625). AKAN has higher annual earnings (EBITDA): -3.86M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. AKAN (3.93M). AKAN has less debt than ACB: AKAN (3.83M) vs ACB (103M). ACB has higher revenues than AKAN: ACB (212M) vs AKAN (111K).
ACBAKANACB / AKAN
Capitalization239M1.25M19,059%
EBITDA-1.64B-3.86M42,406%
Gain YTD13.882-20.625-67%
P/E RatioN/AN/A-
Revenue212M111K190,991%
Total Cash149M3.93M3,790%
Total Debt103M3.83M2,687%
FUNDAMENTALS RATINGS
ACB: Fundamental Ratings
ACB
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACBAKAN
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
50%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FANUY15.070.16
+1.07%
Fanuc Corporation
ICGUF27.50N/A
N/A
Intermediate Capital Group Plc.
CRPHY0.67N/A
N/A
Ceres Power Holdings plc
SLVTF0.43N/A
-1.00%
Silver Tiger Metals Inc.
EMAUF0.20-0.01
-3.10%
EMPEROR METALS INC.

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with CGC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
+0.62%
CGC - ACB
64%
Loosely correlated
+2.70%
OGI - ACB
60%
Loosely correlated
+1.32%
CRON - ACB
56%
Loosely correlated
-0.97%
TLRY - ACB
54%
Loosely correlated
-2.03%
CRDL - ACB
36%
Loosely correlated
+2.86%
More

AKAN and

Correlation & Price change

A.I.dvisor tells us that AKAN and SCYX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKAN and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
+0.79%
SCYX - AKAN
30%
Poorly correlated
N/A
ACB - AKAN
24%
Poorly correlated
+0.62%
CRDL - AKAN
24%
Poorly correlated
+2.86%
TLRY - AKAN
23%
Poorly correlated
-2.03%
CGC - AKAN
23%
Poorly correlated
+2.70%
More